| Stage | J | % of rev | CDNL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.1B | 100.00% | $227M | 100.00% | J ×17.96 |
| Gross profit | $811M | 19.89% | $36M | 15.88% | J +4.0pp |
| Operating income | $287M | 7.03% | $15M | 6.82% | J +0.2pp |
| Pre-tax income | $241M | 5.92% | $10M | 4.47% | J +1.5pp |
| Net income | $136M | 3.33% | $11M | 4.91% | CDNL +1.6pp |
| Stage | J | CDNL | Gap · A − B |
|---|---|---|---|
| Revenue | $4.1B100.00% | $227M100.00% | J ×17.96 |
| Gross profit | 19.89%$811M | 15.88%$36M | J +4.0pp |
| Operating income | 7.03%$287M | 6.82%$15M | J +0.2pp |
| Pre-tax income | 5.92%$241M | 4.47%$10M | J +1.5pp |
| Net income |
| 3.33%$136M |
| 4.91%$11M |
| CDNL +1.6pp |
No disclosed counterparties: CDNL.
None